A carregar...

Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients.

The liposomal formulation of amphotericin B (AmBisome) greatly reduces the acute and chronic side effects of the parent drug. The present study describes the pharmacokinetic characteristics of AmBisome applied to 10 patients at a dose of 2.8 to 3.0 mg/kg of body weight and compares them to the pharm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Heinemann, V, Bosse, D, Jehn, U, Kähny, B, Wachholz, K, Debus, A, Scholz, P, Kolb, H J, Wilmanns, W
Formato: Artigo
Idioma:Inglês
Publicado em: 1997
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC163899/
https://ncbi.nlm.nih.gov/pubmed/9174183
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!